Cochlear Limited (COH.AX)
AUD 262.5
(0.57%)
AUD 262.5
(0.57%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 904.6 Million AUD | 10.33% |
| 2023 | 819.9 Million AUD | 5.2% |
| 2022 | 779.4 Million AUD | 5.82% |
| 2021 | 736.5 Million AUD | -37.67% |
| 2020 | 1.18 Billion AUD | 80.87% |
| 2019 | 653.3 Million AUD | 19.63% |
| 2018 | 546.1 Million AUD | -7.86% |
| 2017 | 592.7 Million AUD | 16.49% |
| 2016 | 508.8 Million AUD | -2.16% |
| 2015 | 520.01 Million AUD | 13.09% |
| 2014 | 459.83 Million AUD | 12.82% |
| 2013 | 407.58 Million AUD | 28.31% |
| 2012 | 317.66 Million AUD | 33.6% |
| 2011 | 237.76 Million AUD | -24.14% |
| 2010 | 313.41 Million AUD | -0.55% |
| 2009 | 315.13 Million AUD | 9.21% |
| 2008 | 288.57 Million AUD | -11.19% |
| 2007 | 324.92 Million AUD | -3.34% |
| 2006 | 336.14 Million AUD | -1.1% |
| 2005 | 339.87 Million AUD | 185.59% |
| 2004 | 119.01 Million AUD | 7.32% |
| 2003 | 110.89 Million AUD | 30.44% |
| 2002 | 85.01 Million AUD | 15.58% |
| 2001 | 73.55 Million AUD | 44.39% |
| 2000 | 50.94 Million AUD | 4.2% |
| 1999 | 48.88 Million AUD | 32.07% |
| 1998 | 37.01 Million AUD | 32.3% |
| 1997 | 27.98 Million AUD | -6.06% |
| 1996 | 29.78 Million AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 748.7 Million AUD | 0.0% |
| 2024 FY | 904.6 Million AUD | 10.33% |
| 2024 Q4 | 904.6 Million AUD | 0.0% |
| 2023 Q4 | 819.9 Million AUD | 0.0% |
| 2023 FY | 819.9 Million AUD | 5.2% |
| 2023 Q2 | 751.4 Million AUD | 0.0% |
| 2022 FY | 779.4 Million AUD | 5.82% |
| 2022 Q4 | 779.4 Million AUD | 0.0% |
| 2022 Q2 | 702.2 Million AUD | 0.0% |
| 2021 Q4 | 736.5 Million AUD | 0.0% |
| 2021 FY | 736.5 Million AUD | -37.67% |
| 2021 Q2 | 719 Million AUD | 0.0% |
| 2020 FY | 1.18 Billion AUD | 80.87% |
| 2020 Q2 | 836.9 Million AUD | 0.0% |
| 2020 Q4 | 1.18 Billion AUD | 0.0% |
| 2019 FY | 653.3 Million AUD | 19.63% |
| 2019 Q2 | 595.4 Million AUD | 0.0% |
| 2019 Q4 | 653.3 Million AUD | 0.0% |
| 2018 Q4 | 546.1 Million AUD | 0.0% |
| 2018 FY | 546.1 Million AUD | -7.86% |
| 2018 Q2 | 609.6 Million AUD | 0.0% |
| 2017 Q2 | 495.97 Million AUD | 0.0% |
| 2017 FY | 592.7 Million AUD | 16.49% |
| 2017 Q4 | 592.7 Million AUD | 0.0% |
| 2016 FY | 508.8 Million AUD | -2.16% |
| 2016 Q4 | 508.8 Million AUD | 0.0% |
| 2016 Q2 | 508.79 Million AUD | 0.0% |
| 2015 Q4 | 520.01 Million AUD | 0.0% |
| 2015 Q2 | 506.31 Million AUD | 0.0% |
| 2015 FY | 520.01 Million AUD | 13.09% |
| 2014 Q4 | 459.83 Million AUD | 0.0% |
| 2014 FY | 459.83 Million AUD | 12.82% |
| 2014 Q2 | 489.25 Million AUD | 0.0% |
| 2013 Q4 | 407.58 Million AUD | -0.77% |
| 2013 FY | 407.58 Million AUD | 28.31% |
| 2013 Q2 | 351.27 Million AUD | 0.0% |
| 2013 Q1 | 351.27 Million AUD | 10.58% |
| 2013 Q3 | 410.74 Million AUD | 16.93% |
| 2012 FY | 317.66 Million AUD | 33.6% |
| 2012 Q4 | 317.66 Million AUD | 0.0% |
| 2011 FY | 237.76 Million AUD | -24.14% |
| 2011 Q4 | 237.76 Million AUD | 0.0% |
| 2010 Q4 | 313.41 Million AUD | 0.0% |
| 2010 FY | 313.41 Million AUD | -0.55% |
| 2009 FY | 315.13 Million AUD | 9.21% |
| 2009 Q4 | 315.13 Million AUD | 0.0% |
| 2008 FY | 288.57 Million AUD | -11.19% |
| 2008 Q4 | 288.57 Million AUD | 0.0% |
| 2007 Q4 | 324.92 Million AUD | 0.0% |
| 2007 FY | 324.92 Million AUD | -3.34% |
| 2006 Q4 | 336.14 Million AUD | 0.0% |
| 2006 FY | 336.14 Million AUD | -1.1% |
| 2005 FY | 339.87 Million AUD | 185.59% |
| 2005 Q4 | 339.87 Million AUD | 0.0% |
| 2004 FY | 119.01 Million AUD | 7.32% |
| 2004 Q4 | 119.01 Million AUD | 0.0% |
| 2003 Q4 | 110.89 Million AUD | 0.0% |
| 2003 FY | 110.89 Million AUD | 30.44% |
| 2002 FY | 85.01 Million AUD | 15.58% |
| 2002 Q4 | 85.01 Million AUD | 0.0% |
| 2001 FY | 73.55 Million AUD | 44.39% |
| 2001 Q4 | 73.55 Million AUD | 0.0% |
| 2000 Q4 | 50.94 Million AUD | 0.0% |
| 2000 FY | 50.94 Million AUD | 4.2% |
| 1999 FY | 48.88 Million AUD | 32.07% |
| 1999 Q4 | 48.88 Million AUD | 0.0% |
| 1998 FY | 37.01 Million AUD | 32.3% |
| 1998 Q4 | 37.01 Million AUD | 0.0% |
| 1997 Q4 | 27.98 Million AUD | 0.0% |
| 1997 FY | 27.98 Million AUD | -6.06% |
| 1996 FY | 29.78 Million AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| 4DMedical Limited | 49.08 Million AUD | -1742.783% |
| Adherium Limited | 3.4 Million AUD | -26453.104% |
| Aroa Biosurgery Limited | 14.77 Million AUD | -6021.0% |
| Atomo Diagnostics Limited | 1.29 Million AUD | -69786.039% |
| Anteris Technologies Ltd | 17.03 Million AUD | -5208.947% |
| Control Bionics Limited | 2.75 Million AUD | -32680.089% |
| CardieX Limited | 8.56 Million AUD | -10464.902% |
| Compumedics Limited | 22.14 Million AUD | -3984.342% |
| CleanSpace Holdings Limited | 6.94 Million AUD | -12916.352% |
| Cyclopharm Limited | 13.65 Million AUD | -6524.822% |
| EMVision Medical Devices Ltd | 5.45 Million AUD | -16480.945% |
| Nova Eye Medical Limited | 8.55 Million AUD | -10477.643% |
| HeraMED Limited | 1.5 Million AUD | -59968.874% |
| Imricor Medical Systems, Inc. | 25 Million AUD | -3517.776% |
| ImpediMed Limited | 6.24 Million AUD | -14389.829% |
| InhaleRx Limited | 911.41 Thousand AUD | -99152.479% |
| LBT Innovations Limited | 5.5 Million AUD | -16323.384% |
| Micro-X Limited | 12.63 Million AUD | -7060.044% |
| Neurotech International Limited | 314.69 Thousand AUD | -287349.277% |
| OncoSil Medical Limited | 1.98 Million AUD | -45540.905% |
| PolyNovo Limited | 37.04 Million AUD | -2342.027% |
| Respiri Limited | 3.55 Million AUD | -25353.183% |
| SomnoMed Limited | 24.78 Million AUD | -3550.452% |
| Universal Biosensors, Inc. | 10.61 Million AUD | -8423.868% |
| Uscom Limited | 2.07 Million AUD | -43525.14% |
| Visioneering Technologies, Inc. | 2.76 Million AUD | -32593.522% |